학술논문

Medication safety in patients with metastatic castrate-resistant prostate cancer treated with enzalutamide or abiraterone - the observational study ENZABI focussing on drug-drug interactions. Supported by the German Cancer Aid within the Comprehensive Cancer Center Erlangen-EMN
Document Type
Journal
Source
ONCOLOGY RESEARCH AND TREATMENT; 2016, 39 p19-p19, 1p. Supplement: 1
Subject
Language
English
ISSN
22965262